INTRODUCTION
Canine babesiosis (CB) is a protozoan disease caused by infection with tick-borne parasites of the genus Babesia with a worldwide distribution and global signifi cance. There are 5 species of this genus infecting dogs, i.e., Babesia canis, B. vogeli, B. rossi, B. gibsoni, and B. conradae [1] . The 3 former species are large forms and the 2 latter species are small forms of Babesia spp in dogs. The most severe form of babesiosis is caused by infection with B. rossi, while B. vogeli is considered the least pathogenic [2] . Clinical signs associated with babesiosis frequently involve lethargy, anorexia, pale mucous membranes, hyperthermia, hemolytic anaemia, hemoglobinuria, and icterus [3] . CME is an infectious disease caused by the rickettsial organism E. canis that affects mainly domestic dogs [4] . CME is another important canine vector-borne disease with a worldwide distribution. Infected animals with ehrlichiosis present several clinical signs that may vary depending on the stage of the disease [5] . The most frequent signs consist of high fever, anorexia, emaciation, hepatomegaly, splenomegaly, lymphadenopathy, cardiac and respiratory disturbance and nervous and ocular alterations [6] . The manifestations of the disease may be affected by the pathogenicity of different E. canis strains and co-infections with other arthropod-borne pathogens such as B. vogeli and Hepatozoon canis transmitted by the same vector [7] .
Acute renal failure may be a severe complication of infection by several species of Babesia, with a prevalence varying from 2.2% to 36% [8] [9] [10] [11] . However, pre-renal azotemia could not be excluded in some of those cases [9] . There is enough evidence to suggest that renal dysfunction is a serious complication associated with CB that has been shown to infl uence the outcome [12, 13] . Therefore, sensitive markers are necessary for the early diagnosis of renal dysfunction in CB. Contrary to babesiosis, scarce reports suggest that E. canis may be a cause of renal dysfunction. Codner et al. [14] indicated a possible glomerulopathy with minimal changes and without histologic evidence of glomerular disease could be seen during acute E. canis infection. Therefore, limited information is available regarding the potential diagnostic or prognostic value of renal markers for this disease in dogs.
In veterinary clinical practice, serum urea and Cre concentrations are widely used as endogenous markers for evaluating RF in dogs and cats because they are easy and inexpensive to perform [15] . Serum Urea is more likely to increase due to pre-renal factors than serum Cre, whereas both parameters are equally likely to increase due to renal diseases [16] . On the other hand, serum Cre usually only becomes elevated once more than 75% of RF is lost.
Serum urea and Cre values can also be infl uenced by extra-renal factors. Over several years serum levels of Cys-C have been considered as a signifi cant marker for fi ltration rate, and the blood protein Cys-C is believed to be an important endogenous marker of RF [17] . Cys-C is a low molecular weight (14 kD) basic protein of the cystatin super family, inhibitors of cystein-proteases, which is produced at a constant rate by all nucleated cells [18] . Therefore, it is freely fi ltered by the renal glomerulus, and entirely catabolized in the proximal tubule [19] . Its fi ltration is unchanged in kidney tubular diseases where its urinary excretion is increased [19] . Cys-C plasma concentration is thus mainly dependent on the glomerular fi ltration rate (GFR) [20, 21] .
Therefore, the purpose of the current study was to predict RF in dogs with babesiosis and ehrlichiosis, by use of indirect serum markers of the reduction of GFR plus a novel biomarker, serum Cys-C, which was measured with species-specifi c commercially available and validated ELISA assay as a reference.
MATERIALS AND METHODS

Animals
A total of 46 mixed breed, 1 to 6 years old dogs of different sex and weights between 16 and 40 kg were enrolled in the study and divided into three groups. Group 
Samples
Venous blood was taken from the cephalic vein, evacuated into a 2 ml plain tube with K3 EDTA (7.5 per cent 0.040 ml) for blood count evaluations, and 10 ml into a Vacutainer without anticoagulant for biochemical analysis. Samples collected into plain tubes were centrifuged at 3000g for 10 min at room temperature. Later, serum samples were separated and stored at −80
• C until analysis. Collected blood samples in EDTA tubes were stored at −80 °C until DNA was extracted.
Determination of B. canis vogeli infection
The diagnosis of babesiosis was confi rmed by direct observation of the protozoa in the blood smears. The identity of the Babesia spp. responsible for the infection was confi rmed by polymerase chain reaction (PCR) and reverse line blot (RLB). PCR was also used to exclude co-infection with E. canis. Only dogs presented with uncomplicated babesiosis caused by B. c. vogeli were included in this study. Uncomplicated babesiosis was defi ned as a clinical presentation attributable to hemolytic anemia only [10] . DNA from frozen blood (200 μl) was extracted using the Wizard ® Genomic DNA Purifi cation Kit (Promega Corporation, Madison, USA). A couple of primer sets was used for PCR. The forward primer RLB-F2 (5'-GACACAGGGAGGTAGTGACAAG-3') and the reverse primer RLB-R2 (biotin-5'-CTAAGAATTTCACCTCTGACAGT-3') were used for the amplifi cation regions conserved for Babesia and Theileria (Table 1) [22] . RLB was performed using PCR products as described by Gubbels et al. [22] and Matjila et al. [23] .
Determination of E. canis infection
Blood smear evaluation was positive for all cases enrolled. DNA extraction was performed according to commercial High Pure PCR Template Prepara tion Kit ® (Roche Diagnostics, Mannheim, Germany). DNA was extracted from 300 ml of frozen whole blood. Amplifi cation PCR was made as described previously by Breitschwerdt et al. [24] . Briefl y, a 50 ml reaction mixture contained 1 μg of template DNA; 200 mM (each) dATP, dTTP, dCTP, and dGTP; 0.05 pmol (each) of the outer primers designated EHR-OUT1 and EHR-OUT2, 12.5 pmol (each) of the inner primers designated GE2f and EHRL3-IP2. Each sample belonging to group E was tested by the use of an ELISA kit (SNAP 4Dx ® , IDEXX Laboratories, USA) as described previously [25] . Aforementioned canine point-of-care ELISA kit detects antibodies of immunodominant proteins of E. canis (p30 and p30-1) [25] .
Serum biochemical analyzes
Serum Urea levels were analyzed within urease UV principle Spinreact ® kits (Cat. No.: 1001332, Spain) and serum Cre levels were analyzed within Jaffe Reaction principle Spinreact ® kits (Cat. No.: 1001110, Spain) in Tokyo Boeki TMS 1024 model automate biochemical analyzer. Serum canine Cys-C levels were measured by sandwich enzyme immunoassay method using Canine Cystatin-C ® ELISA kit (BioVendor, Cat. No.: RD491009100R, Czech Republic) according to the manufacturers instructions. All samples were measured on a spectrophotometer (Digital and Analog Systems S.R.L.) at 450 nm.
Statistical analysis
Data were analyzed by the analysis of variance (ANOVA) means compared by the Tukey test of SAS. Data are expressed as mean ± standard deviation (SD). P<0.001 was assumed as signifi cant. 
DISCUSSION
Immunopathological mechanisms during the course of CB result in systemic infl ammatory response syndrome, multiple organ dysfunction syndrome, haemolysis, and other complications [26] . Injury of the liver, kidney, lungs, pancreas, heart, and brain has been described during the course of CB [27, 28] . During the subclinical phase no clinical signs are evident in CME [29] . For reasons still unclear, certain dogs will progress to the chronic phase of CME. During the chronic phase, signs similar to those seen in the acute phase may occur but with a greater severity. Pale mucous membranes and weakness, bleeding and signifi cant weight loss are common fi ndings in this phase [30] . Contrary to CB, renal signs are less often described in CME.
Diagnostic modalities such as kidney biopsies could have helped to determine the signifi cance of the changes in this study. However, since this study was performed under clinical conditions it was not ethically possible to perform invasive procedures such as serial kidney biopsies in client-owned dogs.
Traditionally, biochemical evidence of renal insuffi ciency is documented with elevations in serum urea and Cre [28, 31] . Their reciprocal plots roughly correlate with GFR [31] . Both urea and Cre require about 60-75 % loss of nephron function before they became elevated [31] . To increase their specifi city, serum urea and Cre are often tested concurrently [32] . In renal disease they are expected to behave similarly with both parameters increasing as GFR decreases [32] . Therefore, serum urea and Cre will only increase when more than 75% of renal functional mass is lost, making them insensitive markers for early detection of renal dysfunction [27] .
Pigmented serum, especially free haemoglobin and/or bilirubin due to haemolysis, is a common fi nding in dogs with babesiosis, resulting in interference with the biochemical tests that rely on photochemistry [16] . One of the biochemical tests is the spectrophotometric analysis of Cre which interferes with bilirubin and haemoglobin. In contrast to Cre, addition of albumin, bilirubin and haemoglobin did not substantially interfere with the measurement of Cys-C in the urine [33] . Moreover, studies conducted on the potential interference of bilirubin, haemoglobin and lipemia in the plasma and sera showed that Cys-C measurement was neither interfered with by icterus nor by haemolysis [34] .
In the current study mean serum urea concentrations were above the reference limit (16-54 mg/dl) only in group H (71.85 mg/dl) with the presence of normal mean serum Cre (1.45 mg/dl) and Cys-C (2.30 mg/L) concentrations. There was a statistical signifi cance (P<0.001) obtained among groups for the mean serum urea concentrations. The reason for elevated mean urea levels might be due to non-renal factors in group H, resulting in an elevated serum Urea:Cre ratio. However, in the present study the cause of elevated Urea:Cre ratio remains undetermined. Recent food over consumption may be a reason of this hyperureagenesis. Other ammonia loading reasons such as, haemolysis, blood transfusions, and gastro-intestinal hemorrhage [35, 36] were all absent in the observed dogs. However, mean serum Cre levels were above the reference limit (0.5-1.4 mg/dl) in group B (1.78 mg/dl), and E (1.53 mg/dl). No statistical signifi cance (P=0.209) was obtained among study groups for mean serum Cre levels. Distinctly, group H had a higher value of mean serum Urea:Cre ratio (59.46 mg/dl) with a statistical signifi cance (P<0.001) between the groups. In human medicine azotemic patients with a serum Urea:Cre ratio of ≥20 indicates pre-renal azotemia, whereas a serum Urea:Cre ratio of <20 presents intrinsic renal disease [37] . The increase of serum Urea:Cre ratio in group H might be due to the ammonia loading as described before. De Scally et al. [16] indicate that serum urea is more likely to increase due to pre-renal factors than serum Cre, whereas both parameters are equally likely to increase due to renal problems. De Scally et al. [32] hypothesized that some dogs in babesiosis with high serum urea and low or normal Cre concentrations may have had renal azotemia. However, a later study by De Scally et al. [16] concluded that elevated serum Urea concentrations in CB in the absence of elevated serum Cre concentrations were not likely to be of renal origin, since serum Cys-C concentrations were not elevated in study dogs with normal serum Cre concentrations. On the comtrary, neither mean serum urea (35.99 mg/dl) nor mean serum Urea:Cre ratio (20.45 mg/dl) in group B were elevated in our study. On the other hand, mean serum Cys-C levels in group B (5.28 mg/L) was found signifi cantly different (P<0.001) when compared to group E (3.02 mg/L) and group H (2.30 mg/L). The fi ndings of the present study are consistent with the previous researches that report renal dysfunction as a serious complication associated with CB [27, 28] . Although, some urinary markers with Cys-C were analyzed in various researches on CB, renal effects of CME were not discussed.
Frank and Breitschwerdt [38] found azotemia in a small percentage of cases, with elevated blood urea nitrogen in 13 dogs and elevated serum creatinine concentration in 7 dogs in a retrospective study of ehrlichiosis in 62 dogs. With the exception of mean serum urea level (40.87 mg/dl) in group E, our results with increased mean serum Urea:Cre ratio (29.38 mg/dl), and mean serum Cre (1.53 mg/dl) levels were in accordance previously published [38] results. On the other hand, mean serum Cys-C (3.02 mg/L) level in group E indicated that RF in CME does not seem to be affected.
In conclusion, our results demonstrate that RF in uncomplicated CB caused by B. c. vogeli seems to be affected based on serum Cys-C concentrations. Contrarily, RF in CME does not seem to be affected by CB. The present manuscript is a preliminary study representing mean serum canine Cys-C levels in dogs with CME. Furthermore, serum urea, and Urea:Cre ratio concentrations should not be used as indicators of RF in CB and CME. Serum canine Cys-C, as a novel RF marker, might be used for early detection of renal injury in both CB and CME.
PROCENA FUNKCIJE BUBREGA KOD BABEZIOZE I ERLIHIOZE PASA PREMA NIVOU CISTATIN-C
PEKMEZCI Didem, URAL Kerem, AYSUL Nuran, GUZEL Murat, CIFTCI Gulay Cilj studije je bio evaluacija koncentracija Cistatin-C (Cys-C) u serumu pasa radi predviđanja funkcionalnog stanja bubrega (RF) pasa prirodno infi ciranih sa Babesia canis vogeli i Ehrlichia canis. Ukupno 46 pasa bilo je podeljeno u tri grupe. Grupu B činilo je 16 pasa, prirodno infi ciranih B. c. vogeli U grupi E bilo je10 pasa, prirodno infi ciranih E. canis [psi kod kojih je dijagnostikovana monocitna erlihioza (ME)], dok se H grupa sastojala iz 20 zdravih (kontrolnih) pasa (negativni na B. c. vogeli i E. canis). Ispitivani su samo psi koji nisu imali komplikovane slučajeve babezioze, već samo babeziozu uzrokovanu B. c. vogeli. Analizirane su koncentracije ureje i kreatinina u serumu, kao i međusobni odnos ovih koncentracija (Urea:Cre). Cys-C u serumu pasa bio je određivan pomoću komercijalno dostupnog i validiranog referentnog ELISA dijagnostičkog testa specifi čnog za vrstu. Srednje vrednosti Cys-C koncentracija u serumu bile su: za grupu B -5,28 mg/L, za grupu E -3,02 Mg/L i za grupu H -2,30 mg/L. Na osnovu koncentracije Cys-C u serumu, uočava se da je funkcionalno stanje bubrega izmenjeno kod nekomplikovanih slučajeva babezioze pasa izazvanih B. c. vogeli. Prema saznanjima autora, radi se o prvoj studiji koja prikazuje da srednje vrednosti Cys-C u serumu pasa nisu uvećane kod monocitne erlihioze pasa izazvane E. canis. Cys-C u serumu pasa može da se koristi kao marker funkcionalnog stanja bubrega, a za ranu detekciju oštećenja bubrega kod babezioze i monocitne erlihioze kod ove vrste životinja.
